Showing results (381-390 of 465) with videos related to
Sort By:
Pageof 47
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 7, 2007
Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitalsE E Udo, N Al-Sweih, R Dhar, et al.Biochemical and Biophysical Research Communications|August 26, 2006
Polo-like kinase 1-mediated phosphorylation of the GTP-binding protein Ran is important for bipolar spindle formationYang Feng, Jin Hui Yuan, Sharon C Maloid, et al.Plos Biology|April 29, 2021
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodiesXing Zhu, Dhiraj Mannar, Shanti S Srivastava, et al.Nature|November 1, 2013
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemiaMasashi Shingai, Yoshiaki Nishimura, Florian Klein, et al.Journal of Virology|November 18, 2016
Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective ImmunotoxinsSeth H Pincus, Kejing Song, Grace A Maresh, et al.Antiviral Research|April 9, 2017
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosetsNeeltje van Doremalen, Darryl Falzarano, Tianlei Ying, et al.Journal of Immunological Methods|November 3, 2006
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panningMei-Yun Zhang, Vidita Choudhry, Igor A Sidorov, et al.Journal of Virology|December 17, 2013
Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6Gilad Ofek, Brett Zirkle, Yongping Yang, et al.AIDS (London, England)|May 16, 2018
A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cellsDesheng Kong, Yan Wang, Ping Ji, et al.NPJ Vaccines|February 9, 2021
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virusThomas W Geisbert, Kathryn Bobb, Viktoriya Borisevich, et al.Pageof 47